This is an excel model about cost-effectiveness analysis on VenO vs. ClbO for treatment-naive CLL patients under the Dutch extented societal perspective.
The excel model details all the assumptions, data inputs, data sources, and data analysis codes used to output the results represented in our article titled: "Cost-effectiveness of Venetoclax plus Obi
